Loading clinical trials...
Loading clinical trials...
A European, Multi-Centre, Multi-Country, Post-Authorisation, Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency (AI)
As a post-approval requirement of the European Medicines Agency, this European patient post authorization safety study is an observational study being conducted to monitor the safety of long-term treatment with Plenadren and other glucocorticoid replacement therapies in routine clinical practice in patients with chronic adrenal insufficiency (primary or secondary).
Age
All ages
Sex
ALL
Healthy Volunteers
No
Charité - Universitätsmedizin Berlin
Berlin, Germany
Endokrinologiepraxis am Stuttgarter Platz
Berlin, Germany
Friedrich Alexander Universitat Erlangen Nurnberg
Erlangen, Germany
Universitätsklinikum Frankfurt
Frankfurt, Germany
LMU Klinikum der Universität München
München, Germany
Medicover Neuroendokrinologie
München, Germany
Medicover Oldenburg MVZ
Oldenburg, Germany
Endokrinologiezentrum Ulm Praxis
Ulm, Germany
Universitätsklinikum Würzburg
Würzburg, Germany
Università degli Studi Federico II
Naples, Italy
Start Date
August 7, 2012
Primary Completion Date
October 31, 2020
Completion Date
October 31, 2020
Last Updated
October 15, 2024
3,258
ACTUAL participants
Lead Sponsor
Shire
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions